Ischemic preconditioning is characterized by resistance to ischemia reperfusion injury in response to previous short ischemic episodes, a protective effect that can be mimicked pharmacologically. The underlying mechanism of protection remains controversial and requires greater understanding before it can be fully exploited therapeutically. To investigate the overall effect of preconditioning on the myocardial proteome, isolated rabbit ventricular myocytes were treated with drugs known to induce preconditioning, adenosine or diazoxide (each at 100 mol/L for 60 minutes). Their protein profiles were then compared with vehicle-treated controls (nϭ4 animals per treatment) using a multitiered 2D gel electrophoresis approach. Of 28 significantly altered protein spots, 19 nonredundant proteins were identified (5 spots remained unidentified). The majority of these proteins are involved in mitochondrial energetics, including subunits of tricarboxylic acid cycle enzymes and oxidative phosphorylation complexes. These changes were not indiscriminate, with only a small number of enzymes or complex subunits altered, indicating a very specific and targeted affect of these 2 preconditioning mimetics. Among the changes were shifts in the extent of posttranslational modification of 4 proteins. One of these, the adenosine-induced phosphorylation of the ATP synthase ␤ subunit, was fully characterized with the identification of 5 novel phosphorylation sites. This proteomics approach provides an overall assessment of the cellular response to pharmacological treatment with adenosine and diazoxide and identifies a distinct subset of enzymes and protein complex subunit that may underlie the preconditioned phenotype. (Circ Res. 2006;99:706-714.) 
I schemic preconditioning (PC) is an endogenous cytoprotective process whereby cells become profoundly resistant to ischemia/reperfusion injury following brief episodes of conditioning ischemia. The initial report of PC described a 76% reduction in cell death in PC compared with control hearts. 1 Protection was found to be transient, lasting 1 to 3 hours following the conditioning trigger, 1, 2 and is now known to be biphasic, resuming after 24 hours to protect for a second phase of 3 to 4 additional days. 3, 4 First described in the heart, PC is a ubiquitous phenomenon that has now been demonstrated in every mammalian tissue type and species examined to date, 5 including humans. 6, 7 PC can also be initiated pharmacologically. Like ischemic PC, pharmacological PC triggers biphasic protection and inhibitors of pharmacological PC block ischemic PC, 5 indicating commonality in their underlying mechanistic properties. A broad range of PC mimetic agents have been identified, encompassing such diverse functions as G proteincoupled receptor (GPCR) agonists (eg, adenosine), potassium channel openers (eg, diazoxide), sodium/hydrogen exchange inhibitors, and volatile anesthetics. 8 Preservation of the preconditioned phenotype across this array of triggers suggests that they share a unifying molecular mechanism and, thus, common effects at the level of the proteome.
The proteome of preconditioned myocardium has not been extensively characterized. To address this, we undertook a broad-based proteomic analysis 9 of an established isolated rabbit ventricular myocyte model of PC. 10, 11 We compared the proteomes of myocytes following 60-minute exposures to PC doses of either adenosine or diazoxide to that of vehicletreated control myocytes. Simultaneous examination of 2 distinct modes of pharmacological PC allowed us to investigate possibilities of congruence or mutual exclusivity of the proteome alterations caused by each treatment. Here we describe extensive changes induced by both adenosine and diazoxide to the myocardial proteome, including alterations to a distinct subset of enzymes and subunits involved in mitochondrial energetics. This includes the characterization of PC-induced posttranslational modification (PTM) to a mitochondrial protein, the ATP synthase ␤ subunit.
Materials and Methods

Isolation and PC of Rabbit Ventricular Myocytes
New Zealand White rabbits (1 to 2 kg) were used in compliance with the Animals for Research Act (Province of Ontario), the Canadian Council on Animal Care, and the Guide for the Care and Use of Laboratory Animals. 12 Rabbit ventricular myocyte isolation and pharmacological PC were performed as described previously, 10, 11 and cells were stored at Ϫ80°C. Cells were isolated from 1 rabbit heart and split into 3 aliquots; each aliquot was either treated with adenosine, diazoxide, or buffer (nϭ4). The use of a homogeneous cell population in the isolated myocyte model of PC eliminated confounding effects possible with multiple cell types present in the heart.
Subproteome Fractionation
Protein extracts were fractionated into HEPES and trifluoroacetic acid (TFA) fractions according to the IN Sequence extraction as described previously, 13, 14 aliquoted and stored at Ϫ80°C. This extraction protocol is robust, reproducible, and minimizes the introduction of artificial PTMs.
Two-Dimensional Gel Electrophoresis
Two-dimensional gel electrophoresis (2-DE) was performed in the first dimension using pH 3 to 10, pH 4 to 7, pH 4.7 to 5.9, or pH 6 to 9 linear gradients (Bio-Rad) and, in the second dimension, either by 10% or 12.5% SDS-PAGE using a Tris-glycine (pH 8.3) running buffer 13 or by 10% bis-Tris SDS-PAGE with 2-(n-morpholino) ethanesulfonic acid (MES) running buffer. 15 Gels were silver stained according to the protocol of Shevchenko et al 16 and quantified (within the linear range of silver stain). Statistically significant protein changes were determined using 2-tailed Student's t tests of the normalized spot intensities between groups using a probability value of Ͻ0.05. Other gels were transferred to nitrocellulose for immunoblotting. More extensive descriptions of 2-DE, image analysis, quantification, and immunoblotting are in the online data supplement, available at http://circres.ahajournals.org.
Protein Identification by Mass Spectrometry
Tryptic digests of excised protein spots were analyzed by matrixassisted laser desorption ionization time of flight (MALDI TOF), mass spectrometry (MS), or electrospray ionization (ESI) tandem MS (MS/MS) (Q-TOF), as described previously. 13, 17 For details, see the online data supplement.
Sequencing of Rabbit ATP Synthase ␤ Subunit
Primers were designed based on the known ATP synthase ␤ subunit sequences and used to amplify overlapping fragments of the coding region from rabbit heart cDNA. The amplified DNA fragments were sequenced at the Johns Hopkins DNA Sequencing Facility. Alignment of ATP synthase ␤ subunit sequences was performed using ClustalW (version 1.83).
Phosphopeptide Analysis by Immobilized Metal Affinity Chromatography
Phosphopeptides were enriched with an immobilized metal affinity chromatography (IMAC) column. 18, 19 All reported phosphopeptide amino acid sequences were manually confirmed. For details see the online data supplement.
Phosphorylated Residue Mapping
The F 1 moiety of the rat mitochondrial ATP synthase 20 was depicted by a ribbon diagram using the Pymol viewer program. Serines and threonines are represented by a sphere model depicting van der Waals radii.
Results
To facilitate quantitative detection and to maximize the likelihood of identifying subtle changes to the proteome, ventricular myocytes from multiple rabbbits were subfractionated into 2 sequential subproteomes, a cytosolic-enriched extract and a myofilament-enriched extract, using an established protocol. 13, 14 Each extract was resolved by 2-DE using 11 different combinations of protein load, the isoelectric focusing (IEF) pH gradients, and the percentage of acrylamide used for SDS PAGE (Figure 1 ). A total of 28 protein spots were consistently and significantly altered. From these spots, 19 nonredundant proteins were identified (5 altered spots were not identified), based on MS analysis by peptide mass fingerprinting and/or MS/MS ( Figure 2 ; Table II in the online data supplement). Diazoxide induced modifications to 15 identified proteins (and all 5 unidentified spots), whereas 13 identified proteins were affected by adenosine (and 3 of the 5 unidentified spots) ( Figure 2 ). A total of 9 identified protein changes were common to both treatments. The majority of the proteins changed in abundance but 4 differed with respect to the presence and distribution of PTMs. Even with this extensive 2-DE analysis of multiple subproteomes, this is not comprehensive list of protein changes; rather, it is an overview of the cellular response with treatment of diazoxide and adenosine. Therefore, to put the protein changes in proper context, it is beneficial to identify those proteins unaffected by these drugs. MS analysis was performed on every wellresolved 2-DE spot, yielding the identities of 135 protein spots (supplemental Table I and Figure I ) that encompassed a number of functional categories. 2-DE is limited in the observation of membrane proteins, as they are very hydrophobic and have difficulty entering the first dimension or focusing; thus we do not observe the membrane spanning subunits of the oxidative phosphorylation (OxPhos) complexes or other proteins.
Proteins Altered by PC
Mitochondrial energetic proteins comprised the majority of identified changes (10/19), including 3 constituents of the tricarboxylic acid (TCA) cycle ( Figure 2A ) and 7 oxidative phosphorylation (OxPhos) subunits ( Figure 2B ). The modulation of these energetics proteins was not indiscriminant; only distinct subsets of proteins were altered. For instance, the TCA cycle enzymes isocitrate dehydrogenase ␣ subunit and ADP-specific succinyl-CoA ligase ␤ chain were observed to increase with diazoxide or both treatments, respectively. However, other several other enzymes in this cycle (citrate synthase, fumarate hydratase, and 2-oxoisovalerate dehydrogenase ␤ subunit [ Figure 2F ]) were observed and remained unchanged with either treatment. Interestingly, subunits within the same enzyme complex were not collectively modulated. For example, the 23-kDa (diazoxide), 24-kDa (diazoxide and adenosine), and 30-kDa (diazoxide and adenosine) subunits of NADH ubiquinone oxidoreductase (complex I) increased in abundance, whereas the 13-and 49-kDa subunits were unaffected ( Figure 2F ).
Mitochondrial changes were not limited to only proteins involved in energetics. Three chaperones also were affected: metaxin 2, prohibitin 1, and heat shock protein 27 (HSP27) ( Figure 2C ). Although these chaperone proteins are involved with similar functions, they are modulated very differently in PC, with prohibitin (adenosine) and HSP27 (diazoxide) increasing and metaxin decreasing (both drugs).
The remainder of identified changes occurred to 6 proteins with a variety of homeostatic functions, including stressresponse elements, regulation of NO or reactive oxygen species (ROS), Ca 2ϩ mobilization, and muscle contraction ( Figure 2D ). Other proteins of similar function or subcellular localization were often observed and unchanged. Of note, myosin light chain (MLC)-1 was altered with a PTM by both drug treatments; yet its partner, MLC-2, was not changed, nor were other myofilament proteins observed (cardiac troponin T, cardiac ␣ actin, and ␣ tropomyosin).
Characterization of PC-Induced PTMs
MLC-1 is among the proteins with an observed PTM. Previously, our laboratory reported, using this same model of PC, that MLC-1 undergoes a novel diphosphorylation on treatment with adenosine, 13 and we have now demonstrated that this also occurs with diazoxide ( Figure 2D ). Three additional proteins underwent PTM with drug treatments: the pyruvate dehydrogenase (PDH) E3-binding protein, ADPribosyl hydrolase, and the ATP synthase ␤ subunit ( Figure 2) . Unfortunately, the modifications to either the E3-binding protein or ADP-ribosyl hydrolase (Figure 2A and 2D, respectively) could not be determined because of insufficient protein quantity or peptide coverage even when spots were pooled from many 2-DE gels. However, E3-binding protein has a known PTM, a reductive acetylation of a lipoylated lysine residue, at K97. 21 The modification of ATP synthase ␤ subunit, a protein subunit of ATP synthase (complex V) is of particular interest, as it is located in the inner mitochondrial membrane and neither it, nor any other inner mitochondrial proteins have previously been observed to have PC induced PTMs. The number of spots assigned to ATP synthase ␤ subunit increased from 2 to 6 when 2-DE resolution was improved by switching from the traditional pH 4 to 7 to a pH 4.7 to 5.9 gel (compare Figure 2B with Figure 3A , respectively). The 6 spots observed with the narrower pH gradient (pH 4.7 to 5.9) were identified by MS as the ATP synthase ␤ subunit, and assessed for their ability to reduce cell death relative to unprotected controls following, but not before, subsequent prolonged ischemic episodes and are unable to address changes occurring to the proteome that prime the preconditioning effect. The outlined method for proteomic analysis (bottom) uses the same conditions demonstrated to induce pharmacological PC, but focuses on the molecular mechanism rather than the effect of pharmacological PC by removing any artifact protein changes potentially caused by the prolonged ischemic event. B, Isolated rabbit ventricular myocytes left untreated or incubated with 100 mol/L adenosine or diazoxide were harvested after 1 h at room temperature (dashed arrow in [A]). Cells were subfractionated into a cytoplasmic-enriched (HEPES) extract and myofilamentenriched (TFA) extract for proteomic 2-DE analysis using a variety of IEF conditions (pH 3 to 10, 4 to 7, and 6 to 9) and SDS PAGE (10 and 12.5% acrylamide). Gels were silver stained, imaged for spot alignment, and quantification. Drugtreated (nϭ4 each) and control gels (nϭ4) were analyzed for statistically significant protein differences. Proteins spots were harvested from one or more dried gels, digested with trypsin, and analyzed by MALDI TOF MS or ESI MS/MS for protein identification. this was confirmed by 2D immunoblot analysis ( Figure 3A) . The pI shift observed is consistent with phosphorylation, as reported recently for ATP synthase ␤ in diabetic human skeletal muscle, 22 but ␤-subunit phosphorylation has not previously been shown to occur in cardiac muscle. To investigate the possibility of phosphorylation, tryptic peptides of these 6 spots obtained from 2-D gels resolved for 3 separate rabbits were enriched for phosphopeptides by IMAC and analyzed by MS/MS for phosphorylation-site identification.
As the amino acid sequence of rabbit ATP synthase ␤ has not previously been determined, it was essential to clone it from rabbit cardiac muscle allowing the accurate matching of the resulting MS/MS spectra and mapping the positions of the phosphorylated amino acid residues. The first 478 amino acids were obtained (supplemental Figure II) , corresponding to all but the last 50 amino acids of all known mammalian sequences (human, bovine, rat, mouse). This protein is highly conserved, differing from the human sequence by only 13 amino acids (Ͼ97% identity). Analysis of MS/MS spectra revealed that ATP synthase ␤ is phosphorylated, at up to 5 amino acid residues in the rabbit heart ( Figure 3B and supplemental Figures III and IV). Phosphorylated serine (S) and threonine (T) residues were identified at the following positions in the rabbit sequence (followed by the corresponding position in the mature rat protein in italics): S106 (S56), T107 (T57), T262 (T212), or S263 (S213), T312 (T262), and T368 (T318). Each of these sites is conserved across many mammalian species (supplemental Figure II) .
The locations of these novel phosphorylated residues were mapped onto the x-ray crystal 3D structure of rat F 1 ATP synthase (96% identical to rabbit sequence) to determine their accessibility in the oligomeric state of the F 1 complex. Based on this model, 20 2 of the phosphorylated amino acid residues, T312 (T262) and T368 (T318), are not accessible in the fully assembled F 1 catalytic complex (of which 1 ␥, 3 ␣, and 3 ␤ subunits constitute the core), indicating that these sites must be phosphorylated before assembly (supplemental Figure V) . The remaining 3 residues, S106 (S56), T107 (T57), and T262/S263 (T212/S213), are accessible and therefore have the potential to be dynamically regulated in the fully assembled state during adenosine treatment. S106 (S56) is located in a loop structure on top of the enzyme within binding distance of the ␣ subunit (at ␣E84 in the mature rat protein). The T262/S263 (T212/S213) sites are located on the side of the enzyme in a loop structure that interacts with another region of the ␤ subunit (at ␤N207 in the rat mature protein).
Discussion
This study was undertaken to assess the cellular response to pharmacological treatment of adenosine and diazoxide, both of which result in a PC phenotype. Although the protein Figure 3 . Characterization of ATP synthase ␤ subunit phosphorylation. A, Silver-stained gels (i and ii) and Western blot (iii) of ATP synthase ␤ subunit from rabbit cardiac tissue separated by 2-DE using a pH 4.7 to 5.9 and 10% SDS-PAGE gel at different protein loads: 200 g (i), 20 g (ii), and 5 g (iii). Protein spots 1 to 6 were excised and analyzed for phospho-peptides by enrichment using IMAC followed by ESI MS/MS. B, Identified phospho-peptide sequences with phosphorylated amino acids labeled as bold and with an asterisk, with additional structural characteristics obtained from molecular modeling indicated. Addition of a single phosphate moiety was detected on fragment 259 to 279, but it was not possible to differentiate whether T262 or S263 was phosphorylated.
changes encompassed a wide number of functional groups, it was the mitochondrial proteins (10/19 identified changes) that dominated the proteome changes (Figure 4 ). It is not surprising that the mitochondria is involved in PC, because several proposed effectors of PC have been either proteins residing, or processes occurring, within mitochondria. 8 signal from the cell surface to the cytosol and mitochondria 26 -30 and are activated within minutes of exposure to a PC stimulus. 31 However, less is known about the ultimate protein targets of these activated kinases. There is strong evidence supporting a role for several candidate protein complexes in the mitochondria specifically, the mitochondrial permeability transition pore protein complex made up of voltagedependent anion channel (VDAC), hexokinase II, and adenine nucleotide translocase (ANT) which has been shown to bind PKC. 32 As well, the succinate dehydrogenase protein complex, which displays functional properties that are similar to the mitochondrial K ATP channel, which on opening (initiated by diazoxide) induces PC. 33 What is not clear is the breadth of the PC targets and how these differ among PC agents. It is striking that the protein changes observed in this broad overview of the myocyte proteome are a defined subset of proteins. Within the mitochondria, the changes are not sweeping, with only a few enzymes targeted, and, in fact, specific subunits of these protein complexes modulated, by the PC stimuli. The specificity of this response indicates that these changes are not random events that may arise for nonspecific NO effects or oxidation but, rather, are targeted effects. The adenosine or diazoxide induced changes were observed in both high abundance proteins (eg, ATP synthase ␤ subunit or MLC-1) as well as in low-abundance proteins (eg, ADP-ribosyl hydrolase or the pyruvate dehydrogenase E3-binding protein), again supporting a targeted action by these drugs. Listed in the online data supplement (supplemental Table II) are the proteins previously observed to be connected to PC (9/19) or ischemia injury (8/19) . The majority of the protein changes described in this study have not been previously connected to PC or ischemia. (See the online data supplement for further discussion of protein functions and possible implications.)
There are 3 protein changes to PDH or TCA cycle subunits ( Figure 2 ) as well as alterations to some, but not all, subunits of the OxPhos complexes I and V, with a single change in complex III (Figure 2 ). Complex I and II have primarily been shown to be inhibited by a number of PC agents. 34 -38 Metabolic effects were proposed in the initial report of PC 1 and further substantiated as a slowing of metabolism. 39, 40 On reperfusion, energetic processes are also preserved by PC, ATP levels recover more rapidly, 41, 42 mitochondrial respiration is better preserved, 43, 44 and postischemic recovery is improved through enhanced coupling between energy production and utilization. 45 Several OxPhos complexes have been mechanistically linked to PC and this study links PC to individual subunits abundance changes or PTMs. These data can lead to more in-depth mechanistic and functional studies of how and why these particular subunits are modulated in PC.
The OxPhos pathway is the primary source of ROS formation in higher organisms, 46 specifically at complexes I and III, 47 and both of these complexes contained altered subunits ( Figure 2B ). Slowing of electron transport by partial inhibition of either complex I or III decreases electron transfer efficiency and thereby promotes ROS formation, a mechanism by which other PC mimetics have been proposed to protect. 48, 49 It is important to note that the OxPhos complexes contain large numbers of integral membrane proteins not easily amenable to 2-DE, so it is possible that not every change was detected by this method.
OxPhos complex V, or F 1 F o ATP synthase, has also been mechanistically linked with PC. In an isolated rat heart model, the protective effect of ischemia or diazoxide PC (at 20 mol/L) was associated with lowered ATP synthase activity. 50 PC doses of diazoxide (ranging from 20 to 50 mol/L) also reduce ATP synthase activity in isolated liver 51 and heart mitochondria. 38, 50 Three of the 4 ATP synthase subunits we identified (d, ␦, and ␤) were altered by PC (Figure 2 ), making them strong candidates for further investigation into defining the mechanism of the inhibitory effect of PC on ATP synthase. It is not clear how increases in the d and ␦ subunits might influence ATP synthase activity. The d subunit is part of the F o H ϩ channel that links electron transport to ATP production, whereas the ␦ subunit forms part of the stator that stabilizes the ATP catalysis portion of F 1 . 52 The extensive phosphorylation of the ␤ subunit is the first report of phosphorylation of this critical enzyme in cardiac tissue and connects a PC stimulus to a PTM of a protein within the mitochondria. Interesting, this subunit has been linked to PC of neuronal cell cultures. PC of cortical neuronal culture with erythropoietin, 53 heat stress, 54 and MK801 54 lead to decreases in 1 protein spot of the ATP synthase ␤ subunit. (See the online data supplement, Table II .) These studies only analyzed the changing protein spots and did not provide data for the unchanged spot identifications; thus these findings could indicate a reduced concentration or change in PTM status. This finding also renews the emphasis of ATP production as either an initiator or effector of PC, as initially speculated in previous PC research. 40 -42 To better understand the significance of the phosphorylated residues, they were modeled onto the 3D x-ray crystallographic structure of the rat F 1 catalytic unit 20 (supplemental Figure V) . The clustering and symmetry of the phosphorylated residues of the ␤ subunit is striking, with all of the residues aligning within each ␤ subunit. All 3 of the accessible phosphorylated residues are located in loop structures that form structural interactions with both the ␣ subunit (S106/ T107 [S56/T57]) and within the ␤ subunit (T262 and S263 [T212 and S213]) and have the potential to regulate function when modulated by adenosine treatment. Experiments to test the functional consequences of these phosphorylations are important to understanding the true function in PC and are ongoing. This finding implies that endogenous mitochondrial kinase or phosphatase activities are influenced during the 60 minutes adenosine treatment and could have larger implications for PC models and signaling to the mitochondria.
Three proteins in addition to ATP synthase ␤ were found to have PC-induced PTMs. As reported previously, adenosine increases the proportion of phosphorylated MLC-1, 13 and diazoxide has now been shown to confer the same effect ( Figure 2D ). ADP-ribosyl hydrolase, including a PTM form, is increased by adenosine and diazoxide. Not previously known to be modified, ADP-ribosyl hydrolase has a broad array of functions. It is among many enzymes involved in NAD ϩ metabolism and also competitively inhibits OxPhos complex I, 55 both of which could influence electron transport during PC. Further analysis is required to uncover its role in PC and to identify the PTM and its potential effect on enzyme activity. As well, diazoxide-induced increase in the PTM form of PDH E3-binding protein (Figure 2A ) could lead to reduced PDH activity via the well-documented phosphorylation of the E1␣ subunit. 21 As described in greater detail in the online data supplement, a chain of events arising from E3-binding protein modification would decrease acetyl coenzyme A (CoA) production, necessary for maintenance of metabolic flux through the TCA cycle.
Implications for PC
Proteome changes induced by 2 different modes of PC in the same model show a distinctive pattern of affected proteins consistent with specific perturbation of mitochondrial metabolism through changes to a selected number of mitochondrial protein complexes. Interestingly, specific mitochondrial subunits of the targeted protein complexes were altered, whereas other remained unaffected, indicating complexity and specificity of the drug response. This may be a general phenomenon. As well, the demonstration that inner mitochondrial protein, ATP synthase ␤ subunit, can be phosphorylated within 60 minutes of treatment with adenosine is intriguing with respect to how kinase/phosphatase activity is regulated within this segregated compartment of the cell. Although mitochondria is central to PC, it is does not have an exclusive role. Our study suggest that, at least, these PC agents have a wider cellular affect but equally selective response to other subproteomes, which suggests these are not random events (Figure 4 ). This study provides an overall assessment of the cellular response adenosine and diazoxide treatment and identifies several protein targets that are both unexpected and novel.
